MedTrace Logo

Aspirin and Thienopyridine Resistance in Peripheral Arterial Disease

NCT03174990 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 195

Last updated 2017-06-05

No results posted yet for this study

Summary

This study evaluates the effects of Aspirin and thienopyridine resistance in relation to clinical cardiovascular outcomes as the genetic predictors of, and outcomes associated with aspirin and thienopyridine resistance in patients with peripheral arterial disease (PAD) currently remain unknown.

Conditions

  • Peripheral Arterial Disease
  • Clopidogrel, Poor Metabolism of

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • khung keong, MD · Cardiovascular interventionalist

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2013-05-17
Completion
2013-12-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03174990 on ClinicalTrials.gov